Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients

Biochemical and Biophysical Research Communications

Volumn 374, Issue 2, 2008, Pages 219-225

  Tanabe, Kazuhiro ^a   Deguchi, Akihiro ^b   Higashi, Mikito ^a,c   Usuki, Hisashi ^b   Suzuki, Yasuyuki ^b   Uchimura, Youichi ^a   Kuriyama, Shigeki ^b   Ikenaka, Kazuhiro ^c  

^a MITSUBISHI CHEMICAL CORPORATION   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Diagnosis; Hepatocellular carcinoma; Liquid chromatography; Liver cirrhosis; Mass spectroscopy; N linked oligosaccharide; Outer arm fucosylation; TMAPA

Indexed keywords

AMMONIUM DERIVATIVE; GLYCAN DERIVATIVE; N ACETYLGLUCOSAMINE; OLIGOSACCHARIDE;

ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FUCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

CARBOHYDRATE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, LIQUID; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FUCOSE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; PHENYLENEDIAMINES; POLYSACCHARIDES; QUATERNARY AMMONIUM COMPOUNDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 50949085700     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.124     Document Type: Article

References (19)

1. Hase S., Ikenaka K., Mikoshiba K., and Ikenaka T. Analysis of tissue glycoprotein sugar chains by two-dimensional high-performance liquid chromatographic mapping. J. Chromatogr. 434 (1988) 51-60
2. Takahashi N. Three-dimensional mapping of N-linked oligosaccharides using anion-exchange, hydrophobic and hydrophilic interaction modes of high-performance liquid chromatography. J. Chromatogr. A 720 (1996) 217-225
3. Otake Y., Fujimoto I., Tanaka F., Nakagawa T., Ikeda T., Menon K.K., Hase S., Wada H., and Ikenaka K. Isolation and characterization of an N-linked oligosaccharide that is significantly increased in sera from patients with non-small cell lung cancer. J. Biochem. (Tokyo) 129 (2001) 537-542
4. Tanabe K., and Ikenaka K. In-column removal of hydrazine and N-acetylation of oligosaccharides released by hydrazionolysis. Anal. Biochem. 348 (2006) 324-326
5. Okamoto M., Takahashi K., and Doi T. Sensitive detection and structural characterization of trimethyl(p-aminophenyl)-ammonium-derivatized oligosaccharides by electrospray ionization-mass spectrometry and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 9 (1995) 641-643
6. Okamoto M., Takahashi K., Doi T., and Takimoto Y. High-sensitivity detection and postsource decay of 2-aminopyridine-derivatized oligosaccharides with matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 69 (1997) 2919-2926
7. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80 (1999) 827-841
8. Brechot C. Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications. J. Hepatol. 4 (1987) 269-279
9. Hoofnagle J.H., and di Bisceglie A.M. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336 (1997) 347-356
10. Comunale M.A., Lowman M., Long R.E., Krakover J., Philip R., Seeholzer S., Evans A.A., Hann H.W., Block T.M., and Mehta A.S. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 5 (2006) 308-315
11. Liu X.E., Desmyter L., Gao C.F., Laroy W., Dewaele S., Vanhooren V., Wang L., Zhuang H., Callewaert N., Libert C., Contreras R., and Chen C. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 46 (2007) 1426-1435
12. Nakagoe T., Sawai T., Tsuji T., Jibiki M.A., Nanashima A., Yamaguchi H., Yasutake T., Ayabe H., Arisawa K., and Ishikawa H. Difference in prognostic value between sialyl Lewis(a) and sialyl Lewis(x) antigen levels in the preoperative serum of gastric cancer patients. J. Clin. Gastroenterol. 34 (2002) 408-415
13. Nakagoe T., Sawai T., Tsuji T., Jibiki M.A., Nanashima A., Yamaguchi H., Yasutake T., Ayabe H., Arisawa K., and Ishikawa H. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients. Anticancer Res. 22 (2002) 451-458
14. Okuda K., Tanaka M., Kanazawa N., Nagashima J., Satomura S., Kinoshita H., Eriguchi N., Aoyagi S., and Kojiro M. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein. Int. J. Oncol. 14 (1999) 65-271
15. Aoyagi Y., Mita Y., Suda T., Kawai K., Kuroiwa T., Igarashi M., Kobayashi M., Waguri N., and Asakura H. The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes. Hepatol. Res. 23 (2002) 287
16. Igarashi H., Aoyagi Y., Suda T., Mita Y., and Kawai K. Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma. Hepatol. Res. 27 (2003) 280-288
17. Aoyagi Y., Suzuki Y., Isemura M., Nomoto M., Sekine C., Igarashi K., and Ichida F. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 61 (1988) 769-774
18. Lee S.J., Evers S., Roeder D., Parlow A.F., Risteli J., Risteli L., Lee Y.C., Feizi T., Langen H., and Nussenzweig M.C. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295 (2002) 1898-1901
19. Callewaert N., Van Vlierberghe H., Van Hecke A., Laroy W., Delanghe J., and Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat. Med. 10 (2004) 429-434